Eyenoviaincis A Commercial Stage Ophthalmic Pharmaceutical Technology Company Based In New Yorklisted On Nasdaq Under The Ticker Symbol Eyenthe Company Specializes In Developing Innovative Therapies And Technologies For Various Eye Diseasesutilizing Its Proprietary Optejet Delivery System Eyenovia S Main Service Involves The Development And Commercialization Of Ophthalmic Treatments Through The Optejet Platformwhich Offers A Safer And More Efficient Method For Administering Eye Medicationskey Products Include Mydcombia Spray For Pupil Dilationclobetasol Propionate Ophthalmic Suspensionfor Pain And Inflammation Post Surgeryand Investigational Therapies Like Micropine For Progressive Myopia And Microline For Presbyopiathe Optejet System Enables Precise Microdosingenhancing The User Experience In Eye Careeyenovia Is Committed To Expanding Its Pipeline Of Microdose Array Print Therapeutics In The Ophthalmic Market
